On the other hand, translation of Sgk1 mRNA was significantly decreased in AF oocytes (Figures 1b and 3b), we decided to supress SGK1 protein kinase activity in YF oocytes using the specific SGK1 inhibitor (GSK‐650394; 10 μM). The gene discussed is WEE1; the disease is atrial fibrillation.